Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept in Advanced Ovarian Cancer with Malignant Ascites
NCT00396591Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2006
- Primary completion
- Nov 2008
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 2 trial of aflibercept in malignant ascites, sponsored by Sanofi. Started Oct 2006; status: completed.
02
Drugs
aflibercept
03
Conditions
malignant ascites
Beyond the preview
Go deeper on NCT00396591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396591.